Global health equity in United Kingdom university research: a landscape of current policies and practices-Reference-Cited by-同舟云学术

Global health equity in United Kingdom university research: a landscape of current policies and practices

Published:2016-10-10 Issue:1 Volume:14 Page:
ISSN:1478-4505
Container-title:Health Research Policy and Systems
language:en
Short-container-title:Health Res Policy Sys

Author:

Gotham Dzintars,Meldrum Jonathan,Nageshwaran Vaitehi,Counts Christopher,Kumari Nina,Martin Manuel,Beattie Ben,Post Nathan

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12961-016-0148-6.pdf

Reference43 articles.

1. Kneller R. The importance of new companies for drug discovery: origins of a decade of new drugs. Nat Rev Drug Discov. 2010;9:867–82.

2. Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R. UK investments in global infectious disease research 1997–2010: a case study. Lancet Infect Dis. 2013;13:55–64.

3. The All-Party Parliamentary Group on Global Health. The UK’s Contribution to Health Globally: Benefiting the Country and the World. 2015. www.appg-globalhealth.org.uk/download/i/mark_dl/u/4009611296/4622063799/The%20UK's%20contribution%20to%20health%20globally_FULL.pdf . Accessed 5 Oct 2016.

4. Office for National Statistics. UK Gross Domestic Expenditure on Research and Development, 2013. 2015. http://www.ons.gov.uk/ons/rel/rdit1/gross-domestic-expenditure-on-research-and-development/2013/stb-gerd-2013.html#tab-Expenditure-on-R-D-Performed-in-the-UK . Accessed 19 Jul 2015.

5. Research Excellence Framework. 2014. http://www.ref.ac.uk/ . Accessed 19 Jul 2015.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of medicines for rare diseases and inborn errors of metabolism: Toward novel public–private partnerships;Journal of Inherited Metabolic Disease;2023-04

2. Evolution of research funding for neglected tropical diseases in Brazil, 2004–2020;PLOS Neglected Tropical Diseases;2023-03-16

3. University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic;Global Public Health;2022-03-17

4. Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register;Clinical Trials;2022-02-16

5. TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines;Pharmaceutics;2021-12-27